Multi-level degenerative disc disease: TDR with Mobi-C artificial disc compared to ACDF .
This report has been verified
by one or more authors of the
original publication.
Diese Studie wurde als potenziell hochrangig eingestuft.
Die KI-gesteuerte High-Impact-Metrik von OE schätzt den Einfluss ein, den eine Arbeit wahrscheinlich haben wird, indem sie Signale sowohl aus der Zeitschrift, in der sie veröffentlicht wurde, als auch aus dem wissenschaftlichen Inhalt des Artikels selbst integriert.
Das mit Hilfe modernster natürlicher Sprachverarbeitung entwickelte OE High Impact-Modell sagt die zukünftige Zitationsleistung einer Studie genauer voraus als der Impact-Faktor einer Zeitschrift allein.
Dies ermöglicht eine frühere Erkennung von klinisch bedeutsamer Forschung und hilft den Lesern, sich auf Artikel zu konzentrieren, die die zukünftige Praxis am ehesten beeinflussen werden.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2014;2(3):22 J Neurosurg Spine. 2013 Nov;19(5):532-45330 patients suffering from cervical degenerative disc disease (DDD) with radiculopathy or myeloradiculopathy at 2 contiguous levels from C-3 to C-7 were randomized to investigate the benefits of cervical total disc replacement (TDR) using the Mobi-C cervical device (LDR Spine) compared with conventional anterior cervical discectomy and fusion (ACDF). The evidence presented in this study indicated that TDR demonstrated statistical superiority over ACDF based on overall study success rates: both TDR and ACDF groups experienced significant improvements in Neck Disability Index (NDI) score, and VAS neck and arm pain at all time points; however TDR patients demonstrated significantly superior NDI scores at all time points compared to ACDF patients, along with significantly superior VAS neck pain at only 3 and 6 months. TDR group maintained preoperative segmental range of motion at both treated segments immediately postoperatively and throughout the study period. Finally, reoperations were significantly higher in the ACDF group compared to the TDR group.
Was the allocation sequence adequately generated?
Was allocation adequately concealed?
Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?
Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?
Blinding Patients: Was knowledge of the allocated interventions adequately prevented?
Was loss to follow-up (missing outcome data) infrequent?
Are reports of the study free of suggestion of selective outcome reporting?
Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?
Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?
Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?
Ja = 1
Ungewiss = 0.5
Nicht relevant = 0
Nein = 0
Die Bewertung der Berichtskriterien bewertet die Transparenz, mit der die Autoren die methodischen und studienspezifischen Merkmale der Studie in der Veröffentlichung angeben. Die Bewertung ist in fünf Kategorien unterteilt, die im Folgenden vorgestellt werden.
2/4
Aleatorización
2/4
Medición de resultados
3/4
Inclusión / exclusión
4/4
Descripción de la terapia
4/4
Estadísticas
Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65
Der Fragilitätsindex ist ein Instrument, das bei der Interpretation signifikanter Ergebnisse hilft und ein Maß für die Stärke eines Ergebnisses liefert. Der Fragilitätsindex gibt die Anzahl der aufeinanderfolgenden Ereignisse an, die zu einem dichotomen Ergebnis hinzugefügt werden müssen, damit das Ergebnis nicht mehr signifikant ist. Eine kleine Zahl steht für ein schwächeres Ergebnis und eine große Zahl für ein stärkeres Ergebnis.
Warum wurde diese Studie jetzt benötigt?
Anterior cervical discectomy and fusion (ACDF) is considered ‘gold standard’ in treating neurological symptoms and neck pain associated with degeneration of intervertebral discs in the cervical spine. ACDF is however associated with hypermobility, increased stress, and increased intradiscal pressures on the segments adjacent to fused level. Cervical total disc replacement (TDR) is an attractive alternative as it addresses the limitations of ACDF by preserving biomechanics at the adjacent segments, allowing for slower degeneration and reduced pain and neurological symptoms. The current research pertaining to the optimal intervention for degenerative disc disease (DDD) remains controversial, especially as the relevant trials have compared TDR and ACDF only at a single level. Multilevel pathologies tend to be more demanding and therefore this study was needed to compare TDR (Mobil-C cervical artificial disc; LDR Medical) against ACDF for symptomatic cervical DDD at 2 contiguous levels of the cervical spine.
Was war die wichtigste Forschungsfrage?
Is there a superior method of fixation for multi-level degenerative disc disease (DDD) between total disc replacement (TDR) with the Mobi-C cervical artificial disc, and anterior cervical discectomy and fusion, as evaluated over 24 months?
- The overall clinical success rate in the TDR group was 69.7% compared to 37.4% in the ACDF group (p< 0.05). TDR patients achieved success earlier than the ACDF patients, and maintained it throughout the study.
- Patients in both the TDR and ACDF groups exhibited a marked improvement from baseline in VAS neck (mean change at 24 months: 54 +/- 25 and 53 +/- 29 respectively) and arm pain (mean change at 24 months: 35 +/- 35 and 34 +/- 38 respectively) at all time points. VAS neck pain scores in TDR patients were significantly superior at 3 and 6 months compared to ACDF patients (p< 0.05).
- Mean change in NDI score at 24 months in the TDR group was 37 +/- 20 compared to 30 +/- 19 in the ACDF group. Both groups improved significantly from baseline but the TDR group demonstrated significantly greater scores at every time point compared to the ACDF group. NDI success was significantly higher in the TDR group at all time points (p< 0.05) with 78.2% of TDR patients compared to 61.8% ACDF patients considered a success at 24 months.
- SF-12 evaluations of TDR patients indicated a mean improvement on the physical (PCS) and mental component (MCS) of 13.5 and 9.5 respectively compared to 10.5 and 7.2 in ACDF patients (p= 0.03 at 24 in favor of TDR).
- 7 (3.1%) TDR patients required a subsequent surgical intervention through 24 month's follow-up (4 removals, 2 reoperations, and 1 revision) compared to 12 (11.4%) of ACDF patients (6 removals; 1 revision; 3 supplemental fixations; and 2 reoperations).
- TDR patients exhibited significantly lower incidence of device-related adverse events with rates of 16.7% (39 of 225 patients) compared to 34.3% (36 of 105 patients) in the ACDF group. 23.9% of TDR patients experienced at least 1 serious adverse event compared to 32.4% ACDF patients; however only 3.4% (8) in the TDR and 14.3% (15) in the ACDF cohorts were definitely or possibly related to the device. Overall 3.6% of TDR patients had major complications with an adverse event compared to 6.7% of ACDF patients.
- 5.6% of TDR patients compared to 6.7% of ACDF groups exhibited significant neurological deterioration. This difference was significantly in favor of TDR (p< 0.0001). TDR patients demonstrated significantly superior radiographic success (p< 0.0001): 96.4% of TDR group patients were classified as radiographically successful compared to 79.8% of ACDF group patients. Differences in adjacent-level degeneration rates were significant in favor of the TDR group for both levels at 12 and 24 month follow-ups (p< 0.03).
- 95.8% of TDR patients were satisfied with their treatment compared to 92.0% of ACDF patients, and 95.8% TDR patients would recommend the surgery to a friend compared to 88.5% ACDF patients.
Was sollte ich mir besonders merken?
Patients in both the cervical total disc replacement (TDR) and anterior cervical discectomy and fusion (ACDF) experienced significant improvements in neck pain, arm pain and disability at all time points. Total disc replacement patients demonstrated significantly superior NDI scores at all time points compared to ACDF patients, along with significantly superior neck pain in the short term (at 3 and 6 months). Total disc replacement patients maintained preoperative segmental range of motion at both treated segments immediately postoperatively and throughout the study period. Reoperations were significantly higher in the ACDF group compared to the total disc replacement group, and the incidence of adjacent-segment degeneration was significantly lower in the TDR group.
Wie wird sich dies auf die Behandlung meiner Patienten auswirken?
The evidence presented in this study demonstrated the noninferiority and potential superiority of cervical total disc replacement using the Mobi-C cervical artificial disc compared with conventional anterior cervical discectomy and fusion in treatment multi-level degenerative cervical disc disease. While the results presented in this study are promising, controversy still remains about differential efficacy between these treatments over an extended period of time. Long-term evaluation of the Mobi-C cervical disc is required to determine if the benefits observed in this trial are maintained, or lost over a longer time frame.
HAFTUNGSAUSSCHLUSS
Der Inhalt dieser Seite dient nur zu Informationszwecken und ist nicht als Ersatz für professionelle medizinische Beratung, Diagnose oder Behandlung gedacht. Wenn Sie eine medizinische Behandlung benötigen, wenden Sie sich immer an Ihren Arzt oder suchen Sie die nächstgelegene Notaufnahme auf. Die Meinungen, Überzeugungen und Standpunkte, die von den Personen auf dieser Seite geäußert werden, spiegeln nicht die Meinungen, Überzeugungen und Standpunkte von OrthoEvidence wider.
